Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots in the People's Republic of China. The company offers Toumai laparoscopic surgical robot; Toumai single port laparoscopic surgical robot; DFVision 3D electronic laparoscope; SkyWalker orthopedic surgical robot; trans-bronchial surgical robot for natural orifice surgery; R-ONE vascular interventional robot for pan vascular surgery; and iSR'obot Mona Lisa robotic trans perineal prostate biopsy system. It is also involved in the distribution of surgical robot devices. The company was founded in 2014 and is headquartered in Shanghai, China. Shanghai MicroPort MedBot (Group) Co., Ltd. operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd.
Frequently asked questions
What sector does Shanghai MicroPort MedBot Group Co Ltd (2252) operate in?
Shanghai MicroPort MedBot Group Co Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Shanghai MicroPort MedBot Group Co Ltd (2252) current stock price?
As of the latest data, Shanghai MicroPort MedBot Group Co Ltd stock price is HK$21.18, with a previous close of HK$21.18.
What is Shanghai MicroPort MedBot Group Co Ltd (2252) current market capitalization?
Shanghai MicroPort MedBot Group Co Ltd market cap is approximately 21.70 billion.
Does Shanghai MicroPort MedBot Group Co Ltd (2252) pay dividends?
No. Shanghai MicroPort MedBot Group Co Ltd does not pay a dividend.
What is Shanghai MicroPort MedBot Group Co Ltd (2252) beta (volatility) score?
Shanghai MicroPort MedBot Group Co Ltd has a beta of 1.464, suggesting it is more volatile than the market.
